CVS Health Corporation (CVS) Income Statement Analysis

See more : China Metal Resources Utilization Limited (1636.HK) Income Statement Analysis – Financial Results

Complete financial analysis of CVS Health Corporation (CVS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CVS Health Corporation, a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.

You may be interested

Viva Wine Group AB (VIVA.ST) Income Statement Analysis – Financial Results
KP Tissue Inc. (KPTSF) Income Statement Analysis – Financial Results
Revelstone Capital Acquisition Corp. (RCACU) Income Statement Analysis – Financial Results
Uber Technologies, Inc. (UT8.DE) Income Statement Analysis – Financial Results
Network18 Media & Investments Limited (NETWORK18.BO) Income Statement Analysis – Financial Results

CVS Health Corporation (CVS)

Industry: Medical - Healthcare Plans

Sector: Healthcare

Website: https://www.cvshealth.com

About CVS Health Corporation

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue	357.78B	322.47B	292.11B	268.71B	256.78B	194.58B	184.79B	177.55B	153.29B	139.37B	126.76B	123.12B	107.08B	95.78B	98.22B	87.47B	76.33B	43.82B	37.01B	30.59B	26.59B	24.18B	22.24B	20.09B	18.10B	15.27B	13.75B	11.83B	9.76B	11.29B	10.44B	10.43B	9.89B	8.69B	7.55B	6.78B	5.93B	5.26B	4.77B
Cost of Revenue	303.35B	267.97B	239.99B	219.66B	211.25B	163.04B	156.26B	148.71B	126.76B	114.00B	102.98B	100.63B	86.52B	75.56B	77.86B	69.18B	60.22B	32.08B	27.31B	22.56B	19.73B	18.11B	16.55B	14.73B	13.24B	11.14B	10.03B	8.47B	6.86B	7.25B	6.66B	6.53B	6.16B	5.37B	4.56B	4.09B	3.57B	3.14B	2.85B
Gross Profit	54.43B	54.50B	52.12B	49.05B	45.53B	31.54B	28.53B	28.83B	26.53B	25.37B	23.78B	22.49B	20.56B	20.22B	20.36B	18.29B	16.11B	11.74B	9.69B	8.03B	6.86B	6.07B	5.69B	5.36B	4.86B	4.13B	3.72B	3.36B	2.90B	4.03B	3.77B	3.90B	3.72B	3.31B	2.99B	2.69B	2.36B	2.12B	1.92B
Gross Profit Ratio	15.21%	16.69%	17.82%	18.25%	17.73%	16.21%	15.45%	16.26%	17.31%	18.20%	18.76%	18.28%	19.20%	21.01%	20.64%	20.91%	21.10%	27.25%	26.76%	26.25%	25.81%	25.10%	25.59%	26.69%	26.86%	27.03%	27.04%	29.08%	32.46%	35.74%	36.14%	37.42%	37.65%	38.15%	39.58%	39.74%	39.84%	40.31%	40.23%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.23B	14.09B	13.93B	12.24B	11.31B	9.30B	7.68B	6.08B	5.10B	4.55B	4.25B	3.74B	3.45B	2.95B	2.78B	2.49B	2.18B	3.22B	2.96B	3.34B	2.91B	2.54B	2.23B	2.02B	1.77B	1.57B	1.41B
Other Expenses	40.69B	46.55B	38.81B	35.14B	33.54B	27.52B	18.99B	18.45B	17.05B	16.57B	15.75B	15.28B	0.00	-10.00M	0.00	-200.00K	0.00	0.00	0.00	496.80M	341.70M	310.30M	673.30M	296.60M	277.90M	249.70M	242.60M	262.80M	327.70M	206.30M	191.60M	201.00M	138.50M	114.40M	97.80M	82.20M	72.00M	64.10M	63.10M
Operating Expenses	40.69B	46.55B	38.81B	35.14B	33.54B	27.52B	18.99B	18.45B	17.05B	16.57B	15.75B	15.28B	14.23B	14.08B	13.93B	12.24B	11.31B	9.30B	7.68B	6.58B	5.44B	4.86B	4.92B	4.04B	3.73B	3.20B	3.02B	2.75B	2.51B	3.42B	3.15B	3.54B	3.05B	2.65B	2.33B	2.11B	1.84B	1.64B	1.47B
Cost & Expenses	344.03B	314.51B	278.80B	254.80B	244.79B	190.56B	175.25B	167.16B	143.82B	130.57B	118.72B	115.91B	100.75B	89.64B	91.79B	81.43B	71.54B	41.38B	34.99B	29.14B	25.16B	22.98B	21.47B	18.76B	16.96B	14.34B	13.05B	11.23B	9.37B	10.67B	9.81B	10.07B	9.22B	8.02B	6.89B	6.19B	5.41B	4.78B	4.33B
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	21.00M	20.00M	21.00M	15.00M	8.00M	4.00M	4.00M	3.00M	5.00M	21.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	2.66B	2.29B	2.50B	2.91B	3.04B	2.62B	1.06B	1.08B	859.00M	615.00M	517.00M	561.00M	588.00M	539.00M	530.00M	530.00M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	4.37B	4.22B	4.49B	4.44B	4.37B	2.72B	2.48B	2.48B	2.09B	1.93B	1.87B	1.75B	1.57B	1.47B	1.39B	1.27B	1.09B	733.30M	589.10M	439.90M	341.70M	310.30M	320.80M	296.60M	277.90M	249.70M	242.60M	262.80M	327.70M	206.30M	191.60M	201.00M	138.50M	114.40M	97.80M	82.20M	72.00M	64.10M	63.10M
EBITDA	18.20B	12.35B	17.53B	17.12B	16.40B	6.74B	11.81B	12.19B	11.57B	10.22B	9.92B	8.62B	7.90B	7.61B	7.82B	7.34B	5.89B	3.17B	2.61B	1.95B	1.77B	1.52B	1.44B	1.62B	1.41B	1.18B	946.70M	867.50M	723.90M	817.00M	814.90M	561.90M	808.10M	778.60M	758.70M	671.80M	595.60M	547.60M	512.10M
EBITDA Ratio	5.08%	6.21%	6.74%	6.91%	6.42%	6.63%	6.49%	7.58%	7.53%	7.71%	7.82%	7.58%	7.37%	7.92%	7.93%	8.37%	7.71%	7.25%	7.05%	6.38%	2.57%	6.27%	8.08%	8.06%	7.81%	8.76%	10.30%	5.54%	14.02%	7.23%	7.79%	5.37%	8.17%	9.07%	10.15%	9.98%	10.11%	10.47%	10.74%
Operating Income	13.74B	7.95B	13.31B	13.91B	11.99B	4.02B	9.54B	10.39B	9.48B	8.80B	8.04B	7.21B	6.33B	6.14B	6.43B	6.05B	4.79B	2.44B	2.02B	1.45B	1.42B	1.21B	770.60M	1.32B	1.14B	930.50M	704.10M	604.70M	396.20M	610.70M	623.30M	360.90M	669.60M	664.20M	660.90M	589.60M	523.60M	483.50M	449.00M
Operating Income Ratio	3.84%	4.89%	4.52%	5.18%	4.67%	2.07%	5.15%	5.82%	6.17%	6.31%	6.34%	5.87%	5.91%	6.39%	6.52%	6.91%	6.28%	5.57%	5.46%	4.75%	1.29%	4.99%	3.46%	6.58%	6.27%	6.09%	5.04%	5.42%	2.00%	5.41%	5.97%	3.46%	6.77%	7.65%	8.75%	8.70%	8.83%	9.19%	9.40%
Total Other Income/Expenses	-2.57B	-2.12B	-2.77B	-4.14B	-2.99B	-2.62B	-1.27B	-1.75B	-859.00M	-1.12B	-509.00M	-905.00M	-584.00M	-536.00M	-525.00M	-509.00M	-434.60M	-215.80M	-110.50M	-58.30M	-48.10M	-50.40M	-61.00M	-79.30M	-59.10M	-239.50M	-466.50M	38.70M	-280.00M	-84.50M	-71.10M	-79.20M	-80.00M	-76.90M	-54.80M	-47.10M	-47.50M	-51.30M	-57.80M
Income Before Tax	11.17B	5.84B	10.54B	9.77B	9.00B	1.41B	8.27B	8.64B	8.62B	7.68B	7.53B	6.31B	5.75B	5.60B	5.90B	5.54B	4.36B	2.23B	1.91B	1.40B	1.38B	1.16B	709.60M	1.24B	1.08B	691.00M	237.60M	643.40M	116.20M	526.20M	552.20M	281.70M	589.60M	587.30M	606.10M	542.50M	476.10M	432.20M	391.20M
Income Before Tax Ratio	3.12%	1.81%	3.57%	3.64%	3.50%	0.72%	4.47%	4.87%	5.62%	5.51%	5.94%	5.14%	5.37%	5.84%	5.99%	6.33%	5.71%	5.08%	5.16%	4.56%	5.17%	4.78%	3.19%	6.19%	5.95%	4.66%	1.22%	7.30%	-8.23%	4.66%	5.29%	2.70%	5.96%	6.76%	8.02%	8.00%	8.03%	8.21%	8.19%
Income Tax Expense	2.81B	1.51B	2.55B	2.57B	2.37B	2.00B	1.64B	3.32B	3.39B	3.03B	2.93B	2.44B	2.26B	2.18B	2.20B	2.19B	1.72B	856.90M	684.30M	477.60M	528.20M	439.20M	296.40M	497.40M	441.30M	306.50M	149.20M	271.00M	58.40M	218.70M	220.40M	125.70M	242.90M	202.00M	208.00M	188.00M	190.70M	193.90M	171.40M
Net Income	8.34B	4.31B	8.00B	7.18B	6.63B	-594.00M	6.62B	5.32B	5.24B	4.64B	4.59B	3.86B	3.46B	3.43B	3.70B	3.21B	2.64B	1.37B	1.22B	918.80M	847.30M	716.60M	413.20M	746.00M	635.10M	384.50M	88.80M	208.20M	-572.80M	307.50M	331.80M	133.40M	346.70M	385.30M	398.10M	354.50M	285.40M	238.30M	210.20M
Net Income Ratio	2.33%	1.34%	2.74%	2.67%	2.58%	-0.31%	3.58%	3.00%	3.42%	3.33%	3.62%	3.15%	3.23%	3.55%	3.74%	3.67%	3.45%	3.12%	3.31%	3.00%	3.19%	2.96%	1.86%	3.71%	3.51%	2.60%	0.30%	1.36%	-6.78%	2.72%	3.18%	1.28%	3.51%	4.44%	5.27%	5.23%	4.81%	4.53%	4.40%
EPS	6.49	3.29	6.00	5.48	5.10	-0.57	6.47	4.93	4.66	3.98	3.77	3.05	2.59	2.51	2.58	2.23	1.97	1.65	1.49	1.13	1.06	0.90	0.51	0.94	0.80	0.48	0.10	0.27	-1.52	0.69	0.60	0.28	0.80	0.90	0.89	0.41	0.66	0.55	0.49
EPS Diluted	6.47	3.26	5.95	5.46	5.08	-0.57	6.44	4.90	4.63	3.96	3.74	3.03	2.57	2.49	2.55	2.18	1.92	1.60	1.45	1.10	1.03	0.88	0.50	0.92	0.78	0.48	0.10	0.26	-1.52	0.69	0.60	0.28	0.80	0.90	0.89	0.41	0.66	0.55	0.49
Weighted Avg Shares Out	1.29B	1.31B	1.32B	1.31B	1.30B	1.04B	1.02B	1.07B	1.12B	1.16B	1.22B	1.27B	1.34B	1.37B	1.43B	1.43B	1.33B	820.60M	811.40M	800.53M	785.57M	784.60M	781.37M	782.25M	782.60M	774.20M	751.00M	426.40M	432.00M	422.55M	525.00M	420.36M	413.63M	410.44M	430.67M	435.81M	432.27M	433.09M	433.20M
Weighted Avg Shares Out (Dil)	1.29B	1.32B	1.33B	1.31B	1.31B	1.04B	1.02B	1.08B	1.13B	1.17B	1.23B	1.28B	1.35B	1.38B	1.45B	1.47B	1.37B	853.20M	841.60M	822.36M	808.45M	810.60M	797.00M	799.34M	817.80M	810.40M	790.53M	426.40M	432.00M	422.55M	529.41M	420.36M	413.63M	410.44M	430.67M	435.81M	432.27M	433.09M	433.20M

3-Stock Lunch: CVS Health, American Express & Lamb Weston

October 18, 2024youtube.com

James Demmert, Main Street Research chief investment officer, join 'Power Lunch' to discuss stock plays for three stocks.

Committee Stocks on the Move: P&G, SLB, Intuitive Surgical and CVS

October 18, 2024youtube.com

The Investment Committee discuss some of their stocks that are on the move.

Events leading up to CVS Health CEO Lynch's departure

October 18, 2024reuters.com

CVS Health CEO Karen Lynch is stepping down after nearly four years at the helm, as the healthcare conglomerate faces shareholder pressure to improve its business performance.

CVS Stock Falls After Karen Lynch Ouster: What to Know

October 18, 2024kiplinger.com

CVS stock is lower Friday after the embattled healthcare company said Karen Lynch is out as CEO, effective immediately

CVS ousts CEO amid tanking shares, activist pressure: ‘Brewing for some time'

October 18, 2024nypost.com

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in its large healthcare insurance business and competition for its vast network of retail pharmacies.

CVS Health Stock Slips on C-Suite Shakeup

October 18, 2024schaeffersresearch.com

CVS Health Corp (NYSE:CVS) stock is down 7.3% at $59.04 at last glance, after news that the company has replaced CEO Karen Lynch with pharmacy benefits executive David Joyner.

CVS shakeup: Stock tumbles on abrupt news that David Joyner will replace CEO Karen Lynch

October 18, 2024fastcompany.com

One of the nation's largest healthcare companies is experiencing a seismic shakeup.

CVS Stock Plummets as It Replaces CEO

October 18, 2024investopedia.com

CVS Health (CVS) stock tumbled about 7% in morning trading Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its...

CVS CEO Shakeup, AXP & PG Earnings

October 18, 2024youtube.com

CVS Health (CVS) announced a change at the top, named a new CEO and released updated 3Q guidance. Friday's early earnings movers all started the day in the red, with Procter & Gamble (PG) and American Express (AXP) each reporting...

CVS Replaces CEO With Caremark President David Joyner

October 18, 2024pymnts.com

CVS has replaced CEO Karen Lynch as it struggles to repair its healthcare business. David Joyner, president of the company's pharmacy benefit management unit Caremark, has been appointed as the new chief executive, CVS announced Friday (Oct. 18).

1 2 3 4 5 6 7 8 9 10

Source: https://incomestatements.info
Category: Stock Reports

CVS Health Corporation (CVS) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories